mutalisk

mutalisk analyzes somatic mutations to correlate mutation patterns with genomic, transcriptional, and epigenomic contexts and to decompose mutations into mutational signatures for studying mutational processes in cancer.


Key Features:

  • Correlation with Genomic Contexts: Integrates somatic mutations with DNA sequence contexts, replication dynamics, RNA transcription activities, and epigenomic chromatin organization to assess the influence of local genomic environment on mutation rates.
  • Identification of Hypermutations: Detects localized hypermutation events (kataegis) characterized by clusters of mutations in specific genomic regions.
  • Decomposition into Mutational Signatures: Dissects somatic mutations into constituent mutational signatures using maximum likelihood estimation to identify and quantify known mutational signatures.
  • Association with Regulatory Elements: Assesses relationships between mutation density and regulatory elements to elucidate impacts on gene regulation and genomic instability.

Scientific Applications:

  • Oncology research: Analyzes the diversity and evolution of mutational processes in cancer genomes.
  • Mutagenic factor inference: Provides insights into mutagenic factors influencing somatic mutations.
  • Clonal evolution and therapeutics: Aids study of clonal evolution in cancer cells and informs therapeutic strategy investigations.

Methodology:

Integrates genomic, transcriptional, and epigenomic data to correlate somatic mutations with biological features, detects kataegis clusters, and uses maximum likelihood estimation to decompose mutation spectra into mutational signatures.

Topics

Details

Tool Type:
web application
Operating Systems:
Linux, Windows, Mac
Added:
6/18/2018
Last Updated:
11/25/2024

Operations

Publications

Lee J, Lee AJ, Lee J, Park J, Kwon Y, Park S, Chun H, Ju YS, Hong D. Mutalisk: a web-based somatic MUTation AnaLyIS toolKit for genomic, transcriptional and epigenomic signatures. Nucleic Acids Research. 2018;46(W1):W102-W108. doi:10.1093/nar/gky406. PMID:29790943. PMCID:PMC6030918.

PMID: 29790943
PMCID: PMC6030918
Funding: - National Cancer Center: NCC-1610450, NCC-1710370, NCC-1711280 - Ministry of Health & Welfare, Republic of Korea: HI16C2387 - Korean Federation of Science and Technology Societies: 162S-1-3-1673

Documentation